PAVmed (NASDAQ:PAVM) Inc. (Nasdaq: PAVM, PAVMZ) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and...
An analyst from BTIG maintained Lucid Diagnostics (NASDAQ: LUCD) at 'buy' with a price target of $2.50 from a prior price target of $3.00. Prior to this rating, Lucid Diagnostics had 5...
Analysts at Cantor Fitzgerald lowered the price target on Lucid (NASDAQ:LCID) Diagnostics Inc (LUCD) to $3.80 (from $4.00) while maintaining an Overweight rating.The analysts comment...
An analyst from Needham & Company maintained Lucid Diagnostics (NASDAQ: LUCD) at 'buy' with a price target of $2.50 from a prior price target of $2.80. Prior to this rating, Lucid...
Investing.com - Lucid Diagnostics (NASDAQ: LUCD) reported third quarter EPS of $-0.22, in line with the analyst estimate of $-0.22. Revenue for the quarter came in at $800K versus the...
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed (NASDAQ:PAVM) Inc....
An analyst from Ascendiant Capital maintained Lucid Diagnostics (NASDAQ: LUCD) at 'buy' with a price target of $9.00 from a prior price target of $9.50. Prior to this rating, Lucid...
Lucid Diagnostics Inc. (Nasdaq: LUCD) and majority-owned subsidiary of PAVmed (NASDAQ:PAVM) Inc. (Nasdaq: PAVM, PAVMZ) ( "PAVmed"), today announced it has released positive data from a...
Investing.com - Lucid Diagnostics (NASDAQ: LUCD) reported second quarter EPS of $-0.23, $0.05 better than the analyst estimate of $-0.28. Revenue for the quarter came in at $159K versus...
PAVmed (NASDAQ:PAVM) Inc. (PAVM, PAVMZ) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital...
Lucid Diagnostics Inc (LUCD) has filed for up to 25,688,308 share offering by selling stockholders.
Investing.com - Lucid Diagnostics (NASDAQ: LUCD) reported first quarter EPS of $-0.24, $0.07 better than the analyst estimate of $-0.31. Revenue for the quarter came in at $446K versus the...
A Canaccord Genuity analyst maintained Lucid Diagnostics (NASDAQ: LUCD) at Buy and a price target of $4.00 from a prior price target of $5.00. Prior to this rating, Lucid Diagnostics had...
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid Diagnostics" or "Lucid"), a commercial-stage cancer prevention diagnostics company and a majority-owned subsidiary of PAVmed (NASDAQ:PAVM) Inc....
An Ascendiant Capital analyst maintained Lucid Diagnostics (NASDAQ: LUCD) at Buy and a price target of $10.00 from a prior price target of $11.00. Prior to this rating, Lucid Diagnostics...
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid Diagnostics" or "Lucid"), a commercial-stage cancer prevention diagnostics company and a majority-owned subsidiary of PAVmed (NASDAQ:PAVM) Inc....
Investing.com - Lucid Diagnostics (NASDAQ: LUCD) reported fourth quarter EPS of $-0.15, $0.18 better than the analyst estimate of $-0.33. Revenue for the quarter came in at $112K versus the...
Lucid Diagnostics Inc. (LUCD) reported Q3 EPS of ($0.28), $0.07 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $80 thousand versus the consensus estimate of...
Investing.com - Lucid Diagnostics reported on Monday third quarter {{erl-1178434||earnings that beat analysts' forecasts and revenue that fell short of expectations. Lucid Diagnostics...
Investing.com – U.S. equities were higher at the close on Tuesday, as gains in the Financials, Consumer Services and Industrials sectors propelled shares higher. At the close in NYSE, the...
Investing.com – U.S. equities were higher at the close on Tuesday, as gains in the Financials, Consumer Services and Industrials sectors propelled shares higher. At the close in NYSE, the...
Investing.com – U.S. equities were higher at the close on Wednesday, as gains in the Financials, Consumer Services and Industrials sectors propelled shares higher. At the close in NYSE, the...
Investing.com – U.S. equities were higher at the close on Wednesday, as gains in the Financials, Consumer Services and Industrials sectors propelled shares higher. At the close in NYSE, the...
Investing.com – U.S. equities were higher at the close on Thursday, as gains in the Financials, Consumer Services and Industrials sectors propelled shares higher. At the close in NYSE, the...
Investing.com – U.S. equities were higher at the close on Thursday, as gains in the Financials, Consumer Services and Industrials sectors propelled shares higher. At the close in NYSE, the...
Investing.com – U.S. equities were higher at the close on Friday, as gains in the Financials, Consumer Services and Industrials sectors propelled shares higher. At the close in NYSE, the...
Investing.com – U.S. equities were higher at the close on Friday, as gains in the Financials, Consumer Services and Industrials sectors propelled shares higher. At the close in NYSE, the...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
